Form 4 for NEPH NEPHROS INC
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-01 · accession 0001062993-25-000264 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-03 | 2025-01-01 | NEPH | Amron Arthur H | Dir | A - Grant | $0.00 | +22.4K | 125.9K | +22% | $0 |
| D | 2025-01-03 | 2025-01-01 | NEPH | Amron Arthur H | Dir | A - Grant | $0.00 | +7,050 | 7,050 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-01 | A | A | 22,418 | $0.00 | 125,881 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-01-01 | A | A | 7,050 | $0.00 | 7,050 | D | $1.47 · — to 2035-01-01 | 7,050 Common Stock | (F2) Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27. |